Eppur si muove, or COPD treatment success and inflammation.
Soriano
J B
JB
Barnes
N C
NC
D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000378:metabolism*; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism*; D016209:Interleukin-8 / Q000378:metabolism*; D009195:Peroxidase / Q000378:metabolism*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D012463:Saliva / Q000276:immunology; D012602:Scopolamine Derivatives / Q000627:therapeutic use*; D000069447:Tiotropium Bromide
D001993:Bronchodilator Agents; D015850:Interleukin-6; D016209:Interleukin-8; D012602:Scopolamine Derivatives; D002097:C-Reactive Protein; D009195:Peroxidase; D000069447:Tiotropium Bromide